Urinary F(2)-Isoprostanes as a Biomarker of Reduced Risk of Type 2 Diabetes

OBJECTIVE: We have previously reported evidence of an inverse association between a urinary F(2)-isoprostane and type 2 diabetes risk in a pilot case-control study nested within the Insulin Resistance Atherosclerosis Study (IRAS). Here, we report the results from the study extended to the entire IRA...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Il'yasova, Dora, Spasojevic, Ivan, Base, Karel, Zhang, Haoyue, Wang, Frances, Young, Sarah P., Millington, David S., D’Agostino, Ralph B., Wagenknecht, Lynne E.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Diabetes Association 2012
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3241306/
https://ncbi.nlm.nih.gov/pubmed/22100959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc11-1502
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg